Researchers discover a potential biomarker for episodic migraine in women.
Researchers report amplified EEG can produce diagnostic results of brain waves associated with migraine and epilepsy non-invasively.
Findings suggest developing HDAC6 inhibitors could be a novel new therapeutic avenue for the treatment of migraines.
According to researchers, Botulinum toxin, or Botox, injections can help to reduce the frequency of chronic migraines. Compared to those treated with a placebo, migraine suffers experienced 1.6 fewer attacks per month following Botox injections.
Study sheds new light on how migraines may occur and why those who are susceptible to migraines see improvements in symptoms as they age.
People who use cannabis to help manage the pain associated with chronic migraine are six times more likely to suffer from rebound headaches, or medication overuse headaches, than those who do not use marijuana.
Neuroimaging study reveals altered structural brain connectivity in patients with chronic and episodic migraines.
The loss of TRESK significantly increases the risk of developing headaches and may be implicated in migraines.
Researchers have identified how a mutation causes dysfunction in a protein, which inhibits neural activity and induces migraines.
Noninvasive vagus nerve stimulation (nVNS) helps improve symptoms of pain and vertigo in patients with vestibular migraines.
Migraine sufferers who embarked on two-and-a-half hours of moderate to vigorous exercise per week reported a significant decline in their migraine triggers, including stress, depression, and sleep problems.
A new study reveals a connection between light sensitive nerve cells in the eyes and areas of the brain that regulate mood. The findings may help explain how light can induce some of the negative emotions that often accompany migraines.
